Cite
Razzouk BI, Heideman RL, Friedman HS, et al. A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer. 1995;75(11):2762-7doi: 10.1002/1097-0142(19950601)75:11<2762::aid-cncr2820751121>3.0.co;2-2.
Razzouk, B. I., Heideman, R. L., Friedman, H. S., Jenkins, J. J., Kun, L. E., Fairclough, D. L., & Horowitz, M. E. (1995). A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer, 75(11), 2762-7. https://doi.org/10.1002/1097-0142(19950601)75:11<2762::aid-cncr2820751121>3.0.co;2-2
Razzouk, B I, et al. "A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors." Cancer vol. 75,11 (1995): 2762-7. doi: https://doi.org/10.1002/1097-0142(19950601)75:11<2762::aid-cncr2820751121>3.0.co;2-2
Razzouk BI, Heideman RL, Friedman HS, Jenkins JJ, Kun LE, Fairclough DL, Horowitz ME. A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer. 1995 Jun 01;75(11):2762-7. doi: 10.1002/1097-0142(19950601)75:11<2762::aid-cncr2820751121>3.0.co;2-2. PMID: 7743483.
Copy
Download .nbib